[Front-line research: Multi-route gradient breakthrough, commercialization of brain-computer interface still awaits ecological breakthrough] On November 11, a coin-sized implant was implanted in the brain, and patients with high paraplegia can control robotic arms, online shopping, etc. with just their "thoughts". This is the latest clinical trial result of Ladder Medical WRS 01. The pace of clinical transformation of technologies that once remained in science fiction continues to accelerate. Reporters recently visited Shanghai Ladder Medical Technology Co., Ltd. (Ladder Medical), Beijing Xinzhida Neurotechnology Co., Ltd. (Xinzhida), Xiangyu Medical and other industrial chain companies and found that the domestic brain-computer interface track is advancing collaboratively at multiple points: clinical registration of semi-invasive and invasive related products is progressing in an orderly manner, independent research on core components such as electrodes continues to deepen, and non-invasive brain-computer rehabilitation equipment is accelerating the implementation of medical institutions. The industry has gradually bid farewell to the extensive competition of proof-of-concept and one-sided competition of channel parameters, and has entered a new cycle with long-term safety and clinical effectiveness as the core criteria. The popularity of the track continues to rise, but most products are still in the clinical verification cycle, and industrialization still faces multiple tests. With the implementation of the international standard for the brain-computer interface reference architecture led by China, capital, clinical, and industrial chains are speeding up together to promote brain-computer technology from the laboratory to real medical scenarios. (China Securities Journal)